National Institute Of Neurological Disorders And Stroke (ninds)
Clinical trials sponsored by National Institute Of Neurological Disorders And Stroke (ninds), explained in plain language.
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab (Keytruda), a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog and dizziness in people with long COVID. Fifteen adults who had COVID-19 at least six months ago and still have…
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Jul 01, 2026 23:00 UTC
-
New injection could ease severe cancer bone pain
Symptom relief Not yet recruitingThis early-stage trial tests a drug called resiniferatoxin (RTX) for people with severe bone pain from cancer that hasn't been helped by standard treatments. About 30 adults will receive a single injection into the spine to see if it safely reduces pain. The study will track pain…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
Knowledge-focused Not yet recruitingThis study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC